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Summary  This  study  investigated  the  variations  in  some  cells  of  the  immune  sys-
tem,  as  well  as  the  antibiotic  resistance  of  the  bacteria  responsible  for  enteric
infections  among  HIV+  patients  compared  to  HIV− patients  in  Mbouda  AD  LUCEM
Hospital,  Cameroon.
A cross-sectional  study  was  performed  from  September  2014  to  February  2015  in
67  human  immunodeﬁciency  virus  (HIV)-seropositive  (HIV+)  and  37  HIV-seronegative
(HIV−)  patients.  Blood  collected  from  these  patients  was  used  to  perform  clus-
ter  of  differentiation  4  (CD4)  and  cluster  of  differentiation  8  (CD8)  lymphocyte
blood  counts  and  a  white  blood  cell  count,  as  well  as  to  measure  C-reactive  protein
(CRP)  blood  by  ﬂow  cytometry  and  perform  optical  and  immuno-turbidimetric  detec-
tion.  Enteric  bacteria  were  isolated  from  the  stool  of  patients,  and  their  antibiotic
susceptibility  proﬁles  were  determined  using  agar  diffusion  methods.The  results  showed  that  Escherichia  coli  was  the  main  pathogenic  bacteria  in
the  digestive  tracts  of  HIV+  (85.3%)  and  HIV− (81.1%)  patients,  and  infections
with  Klebsiella  sp.  were  also  predominant  among  HIV− patients  (29.4%).  Resis-Please  cite  this  article  in  press  as:  Marbou  WJT,  Kuete  V.  Bacterial  resistance  and  immunological  proﬁles  in  HIV-
infected  and  non-infected  patients  at  Mbouda  AD  LUCEM  Hospital  in  Cameroon.  J  Infect  Public  Health  (2016),
http://dx.doi.org/10.1016/j.jiph.2016.04.009
tance  of  Klebsiella  sp.  to  ceftriaxone  (CRO;  P =  0.001),  gentamicin  (GEN;  P  =  0.005),
chloramphenicol  (CHL;  P  =  0.0004),  ciproﬂoxacin  (CIP;  P  =  0.005)  and  doxycycline
(DOX;  P  <  0.0001)  was  signiﬁcantly  higher  in  HIV+  patients  than  in  HIV−  patients.
Abbreviations: AIDS, acquired immunodeﬁciency syndrome; HIV, human immunodeﬁciency virus; HIV+, seropositive for HIV; HIV−,
eronegative for HIV; CD, cluster of differentiation; CRP, C-reactive protein; AMO, amoxicillin; AMC, amoxicillin + clavulanic acid; CRO,
eftriaxone; GEN, gentamicin; CHL, chloramphenicol; CIP, ciproﬂoxacin; LEV, levoﬂoxacin; TET, tetracycline; DOX, doxycycline; NT,
ot tested; S, signiﬁcant; NS, non-signiﬁcant.
∗ Corresponding author at: P.O. Box 67, Dschang, Cameroon. Tel.: +237 77 35 59 27; fax: +237 22 22 60 18.
E-mail addresses: marboutakougoum@yahoo.fr (W.J.T. Marbou), kuetevictor@yahoo.fr (V. Kuete).
ttp://dx.doi.org/10.1016/j.jiph.2016.04.009
876-0341/© 2016 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier Limited. All rights reserved.
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Introduction
Enteric  diseases  are  among  the  primary  causes  of
morbidity  and  mortality  in  low  income  countries.
Acquired immunodeﬁciency  syndrome  (AIDS),
which is  responsible  for  immune  depression,
increases  the  incidence  of  enteric  diseases.  Inter-
est in  topics  related  to  infection  with  human
immunodeﬁciency  virus  (HIV)  and  opportunist
diseases continues.  Indeed,  HIV  infects  T4  lympho-
cytes,  monocytes,  macrophages,  Langerhans  cells,
dendritic  follicular  cells  of  the  ganglia  and  the
cerebral astrocytes  due  to  the  CD4  protein  recep-
tors of  this  virus  [1].  The  principal  consequence
of infection  with  HIV  is immune  depression  of  the
infected  person,  rendering  him  or  her  vulnerable
to opportunistic  infections.
Resistance  of  the  enteric  bacteria  to  antibiotics
remains a  major  cause  of  morbidity  and  mortality
worldwide. In  people  living  with  HIV/AIDS  in  devel-
oping  countries,  enteric  diseases  represent  the
second  most  common  cause  of  death  after  tuber-
culosis  [2].  As  immunodeﬁciency  progresses  due
to HIV  infection,  the  most  opportunistic  diseases
are observed  when  CD4  counts  fall  to  less  than
200 cells/L  of  blood  [3]. Prophylactic  antibiother-
apy is  administered  when  the  immunodeﬁciency
becomes  severe.  This  practice  can  lead  to  the
development of  bacterial  resistance.  Immunodeﬁ-
ciency and  the  presence  of  the  bacteria  resistant
to standard  antibiotics  among  patients  endanger
their prognoses.  In  light  of  the  disordered  state  of
the defense  mechanisms  caused  by  HIV  infection,
we believed  that  it  could  have  a  connection  withPlease  cite  this  article  in  press  as:  Marbou  WJT,  Kuete  V.  B
infected  and  non-infected  patients  at  Mbouda  AD  LUCEM  
http://dx.doi.org/10.1016/j.jiph.2016.04.009
colonization of  the  cells  of  the  immune  system  and
the development  of  bacterial  resistance  respon-
sible for  enteric  infections.  Many  authors  have  been
t
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 resistance  to  GEN  (P  =  0.009)  and  CIP  (P  =  0.001)  in  HIV+
atients.  Citrobacter  sp.  was  resistant  to  GEN  (P  =  0.009)
o  HIV− patients.  Salmonella  sp.  showed  high  resistance
P  <  0.0001)  in  HIV+  patients  compared  to  HIV−  patients.
AMO  (P  =  0.005),  AMC  (P  =  0.005)  and  CHL  (P  =  0.005)  was
atients  than  in  HIV− patients.  Lymphopenia  was  higher
 in  HIV− patients  (2.7%).  In  45.9%  of  the  HIV− patients,
n  6  mg/L  compared  to  16.2%  in  HIV+  patients.  In  gen-
istance  in  HIV+  patients  (79.4%)  was  signiﬁcantly  higher
ients  (29.7%).
hat  the  resistance  proﬁles  of  bacteria  should  be  consid-
 to  improve  their  health  care.
ziz  University  for  Health  Sciences.  Published  by  Elsevier
nterested  in  evaluating  enteric  infections  from
arious  aspects  such  as  epidemiology  and  clinical
ccurrence,  as  well  as  therapeutic  interventions,
o ﬁght  against  them.  To  the  best  of  our  knowledge,
nly a few  studies  have  combined  the  immunolog-
cal aspects  of  these  infections,  HIV  and  bacterial
esistance. Thus,  we  proposed,  in  this  work,  to
tudy the  variations  in  some  cells  of  the  immune
ystem, as  well  as  the  sensitivity  of  the  bacteria
esponsible for  enteric  infections  among  HIV+
atients compared  to  HIV−  patients  in  Mbouda  AD
UCEM Hospital,  a  reference  heath  care  unit  in  the
est Region  of  Cameroon.
ethods
tudy area
his  work  was  performed  in  the  Biochemistry,
aematology  and  Bacteriology  Laboratories  of
bouda AD  LUCEM  hospital  located  in  the  Bam-
outos  division,  more  precisely  in  the  downtown
rea of  Mbouda,  West  Region  of  Cameroon.  This
rea was  selected  for  the  study  based  on  its
ood reputation  in  the  management  of  HIV-infected
atients.
opulation of the study
n  this  study  sixty-eight  HIV+  and  thirty-seven
control group)  HIV−  patients  were  enrolled.  The
onsenting  participants  had  physicians  who  pre-
cribed stool  examinations,  and  also  included  inacterial  resistance  and  immunological  proﬁles  in  HIV-
Hospital  in  Cameroon.  J  Infect  Public  Health  (2016),
his study  were  patients  who  had  not  received  any
peciﬁc antibacterial  therapy  in  the  previous  two
eeks. Not  included  in  this  study  were  pregnant
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acterial  resistance  and  immunological  proﬁles  in  H
omen,  diabetic  patients,  victims  of  burns,
atients receiving  estrogens  and  smokers.
tudy design
his  study  was  a  cross-sectional  analysis  to
etermine the  immunological  and  microbiological
roﬁles of  bacteria  responsible  for  enteric  infec-
ions in  HIV+  patients  and  HIV−  control  patients.
thics approvals
thical  clearance  for  this  study  was  obtained  from
he Ethics  Review  and  Consultancy  Committee  of
he Cameroon  Bioethics  Initiative  (CAMBIN)  under
eference  number  CBI/295/ERCC/CAMBIN  of  16
eptember  2014.  Authorization  to  collect  and  ana-
yze blood  samples  was  also  obtained  from  the
bouda  AD  LUCEM  hospital.  All  of  the  participants
ere duly  informed  of  the  study  goals,  procedures,
otential harm  and  beneﬁts,  and  cost,  as  well  as
he ﬁnality  of  the  study.  They  willingly  provided
nformed consent,  either  by  signing  or  placing  their
humbprint  on  the  consent  form  after  being  satis-
ed with  the  responses  to  all  questions  asked  of  the
nvestigators.  Information  was  provided  in  English
r French  or  interpreted  in  the  local  dialect  by  a
olunteer  independent  of  the  study  team.  Partici-
ants’  blood  samples  and  results  were  anonymized.
eftover blood  and  stool  samples  were  destroyed,
ccording to  hospital  biosafety  procedures.
aboratory examination
IV  testing
creening  for  HIV  sero-status  was  performed  using
raQuick  HIV  (Ora  Sure  Technology,  USA)  test  kits,
s described  by  the  manufacturers  and  as  previously
eported  [4].
ollection  of  blood  and  stool  samples
he  skin  surface  was  cleaned  with  70%  ethanol
nd then  10  mL  of  blood  were  collected  and  dis-
ributed immediately  after  collection  into  three
ubes,  including  two  EDTA  tubes  for  white  blood
ells and  CD4/CD8  lymphocytes  counts  and  a  dry
ube for  the  CRP  level.  For  the  stool  samples,  the
ands were  washed  in  an  aseptic  manner  and  then
insed with  tap  water.  Subsequently,  we  obtain
pproximately 10  g  of  stool  in  a  sterile  bottle,
aking care  not  to  touch  the  upper  edge  of  the  bot-Please  cite  this  article  in  press  as:  Marbou  WJT,  Kuete  V.  B
infected  and  non-infected  patients  at  Mbouda  AD  LUCEM  
http://dx.doi.org/10.1016/j.jiph.2016.04.009
le. The  bottle  was  then  closed  hermetically  and
abeled  and  transported  in  a  cooler  to  the  lab-
ratory for  bacterial  analyses  within  5—15  min  of
ollection.
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ulture  media  and  antibiotic  disks
solation  media  commonly  used  for  the  isolation
f enteric  bacterial  pathogens  were  employed  in
his study.  They  consisted  of  Shigella-Salmonella
gar (S-S  agar),  eosin  methylene  blue  agar  (EMB),
ektoen  agar,  nutritive  agar,  Muller  Hinton  agar,
nd Usual’s  antibiotic  disks.  The  antibiotic  disks
ere purchased  from  Verna  Industrial  Estate,  Verna
oa, India.  They  were  amoxicillin  (AMO,  25  g),
moxicillin  +  clavulanic  acid  (AMC,  20/10  g),  cef-
riaxone (CRO,  30  g),  gentamicin  (GEN,  15  g),
hloramphenicol  (CHL,  30  g),  ciproﬂoxacin  (CIP,
 g),  levoﬂoxacin  (LEV,  5  g),  tetracycline  (TET,
0 IU),  and  doxycycline  (DOX,  30  IU).
solation  of  bacterial  enteric  pathogens
tool  specimens  were  collected  and  processed  in
he same  manner  in  all  of  the  HIV+  and  HIV−
atients. For  the  isolation  of  pathogenic  enteric
acteria,  stool  suspension  was  prepared  in  5  mL
f sterile  physiological  water.  Each  suspension  was
own thereafter  on  selective  and  differential  cul-
ure media  in  Petri  dishes  for  the  isolation  of  enteric
acteria  (EMB  agar,  Hektoen  and  SS  agar).  The
etri dishes  were  then  incubated  at  37 ◦C  for  24  h.
olonies of  Escherichia  coli  were  dark  purple  with
 metallic  surface  on  EMB  agar,  yellow  on  Hek-
oen and  more  or  less  mobile  with  a fresh  state
n microscopic  observation.  Colonies  of  Klebsiella
p. were  pink  with  a violet  center,  convex  without
etallic surfaces  on  EMB  agar,  yellow  on  Hektoen
nd not  mobile  with  a  fresh  state  on  microscopic
bservation.  Colonies  of  Citrobacter  sp.  were  pale
iolet with  a  center,  and  a  metallic  characterized
t on  EMB  agar,  while  it  was  yellow  on  Hektoen  and
obile with  a  fresh  state  on  microscopic  obser-
ation. Colonies  of  Enterobacter  sp.  had  a bluish
spect on  EMB  agar  and  were  yellow  on  Hektoen
nd mobile  with  a  fresh  state  on  microscopic  obser-
ation. Colonies  of  Salmonella  sp.  were  colorless
ith a  black  center  on  SS  agar,  blue-green  with  a
lack center  on  Hektoen,  and  grayish  transparent
n EMB.  These  colonies  were  mobile  with  a fresh
tate on  microscopic  observation.  The  colonies  of
erratia sp.  were  colorless  with  a gray  center  on
S agar  and  mobile  with  a fresh  state  on  micro-
copic observation.  Colonies  of  Proteus  sp.  were
ellow  with  a  black  center  on  Hektoen  agar,  gray-
sh with  a ﬁlm  around  the  colony  on  EMB  agar
nd very  mobile  with  a fresh  state  on  microscopic
bservation.  Each  colony  was  isolated  and  puri-
ed by  culture  on  nutritive  agar  at  37 ◦C  for  18  h,acterial  resistance  and  immunological  proﬁles  in  HIV-
Hospital  in  Cameroon.  J  Infect  Public  Health  (2016),
nd conﬁrmation  was  realized  by  the  study  of  bio-
hemical  proﬁles  on  the  API  20E  gallery  conform,
s described  by  the  manufacturer  (Bio  Merieux,
yon, France)  [5]. The  conﬁrmation  of  the  bacterial
 INJIPH-574; No. of Pages 8
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4  
species  was  performed  according  to  the  established
biochemical characteristics  (see  Table  S1;  suppor-
ting information).
Antibiotic  susceptibility  testing
Agar diffusion  in  solid  medium  was  used  to  evalu-
ate the  susceptibility  of  the  isolates  to  antibiotics,
as described  by  CLSI  (2013).  An  inoculum  of  opac-
ity of  0.5  Marc  Farland  (108 bacteria  per  mL)  was
inoculated  on  Muller  Hinton  agar  for  all  of  the  iso-
lates. On  a  dry  surface  of  Muller  Hinton  agar  4 mm
thick, bacteria  were  inoculated  by  ﬂooding.  The
antibiotic  disks  were  deposited  thereafter  on  the
surface of  the  agar  using  a  sterile  grip  (5  disks  of
antibiotics  in  one  Petri  dish  of  90  mL).  Each  disk
was pressed  to  ensure  complete  contact  with  the
agar and  was  distributed  so  that  the  center  of  each
disk is  located  at  25  mm  from  the  others.  Each  Petri
dish was  allowed  for  3—5  min  to  undergo  diffusion  of
antibiotics  and  then  was  reversed  and  placed  in  an
incubator  (Prolabo,  Medical  international,  Rochin,
France)  at  37 ◦C  for  24  h.  The  resulting  zones  of
inhibition were  measured  to  the  nearest  whole  mil-
limeter using  a  meter  ruler  and  were  interpreted
using the  standards  of  CLSI.  Performance  stan-
dards  for  antimicrobial  susceptibility  testing  and
the organisms  were  reported  as  susceptible  (S),
intermediate  (I)  or  resistant  (R)  to  the  antibiotic
being tested  (see  Table  S2;  supporting  information).
CD4 and  CD8  counts  and  C-reactive  protein
levels
The CD4  and  CD8  T-lymphocytes  counts  of  all
of the  participants  were  determined  using  ﬂowPlease  cite  this  article  in  press  as:  Marbou  WJT,  Kuete  V.  B
infected  and  non-infected  patients  at  Mbouda  AD  LUCEM  
http://dx.doi.org/10.1016/j.jiph.2016.04.009
cytometry  applied  in  clinical  immunology  by  the
Becton  Dickinson’s’  FACS  count  method  [6]  The
level of  C-reactive  protein  (CRP)  was  determined
by immunoturbidimetry  techniques  [7].
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Figure  1  Distribution  of  the  bacterial  infections  in  H PRESS
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lood  count
lood was  collected  in  pre-labeled  EDTA  tubes.
hen, the  tubes  were  gently  agitated  to  avoid
he formation  of  clots.  Each  sample  was  then
ntroduced into  an  automat  (Hemascreen  18;  Hos-
itex diagnosis;  Florence,  Italy).  After  9  s,  the
utomat calculated  and  automatically  reported
hite blood  cell,  lymphocyte,  monocyte  and  gran-
locyte  counts.
tatistical  analysis
ummary  statistics  of  demographics  and  clinical
haracteristics  were  calculated  for  patients  with
nd without  HIV.  To  examine  the  association  HIV
tatus with  patients’  demographic  and  clinical
haracteristics, we  used  the  chi-square  test  for  cat-
gorical variables  and  the  t  test  for  continuous
ariables. A  P-value  of  ≤0.05  was  considered  to  be
tatistically  signiﬁcant.
esults
f  the  68  HIV+  patients,  44  (64.70%)  were  women,
nd 24  (35.30%)  were  men.  Of  the  37  HIV−  patients,
1 (56.76%)  were  women,  and  16  (43.24%)  were
en. Compared  to  the  HIV+  patients,  the  HIV−
atients  were  younger,  with  ages  between  31  and
0 years  old  more  represented  in  HIV+  patients,
nd there  was  a signiﬁcant  association  between  HIV
tatus and  age  group  (2 (1)  = 25.054,  P  < 0.0001;
able  S3;  supporting  information).  Table  S3  also
hows signiﬁcantly  higher  multi-drug  resistance
P <  0.0001)  in  HIV+  patients  than  in  HIV−  patients.
The distribution  of  the  bacterial  species  respon-
ible for  enteric  infections  in  the  two  populationsacterial  resistance  and  immunological  proﬁles  in  HIV-
Hospital  in  Cameroon.  J  Infect  Public  Health  (2016),
s represented  in  Fig.  1. It  appeared  that  the  dis-
ribution  of  infections  with  E.  coli  was  higher  in
IV+ patients  than  in  HIV−  patients  in  this  study.
he prevalence  of  infections  with  Klebsiella  sp.  was
IV− and  HIV+  patients:  37  (HIV−) and  68  (HIV+).
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tigure  2  Distribution  of  CD4  cells,  CD8  cells  and  CD4/CD
igher  in  HIV+  (29.4%)  patients  than  in  HIV−  (2.7%)
atients.
The distribution  of  resistance  of  the  various  bac-
erial isolates  to  antibiotics  was  also  determined.
esistance of  Klebsiella  sp.  to  CRO  (P =  0.001),
EN (P  =  0.005),  CHL  (P  = 0.0004),  CIP  (P  = 0.005)
nd DOX  (P  <  0.0001)  was  signiﬁcantly  higher  in
IV+ patients  than  in  HIV−  patients.  Enterobac-
er sp.  showed  highly  signiﬁcant  resistance  to  GEN
P = 0.009)  and  CIP  (P  =  0.001)  in  HIV+  patients,
ompared to  HIV−  patients.  Citrobacter  sp.  was
esistant to  GEN  (P  =  0.009)  in  HIV+  patients,  com-
ared to  HIV−  patients.  Salmonella  sp.  showed
ighly signiﬁcant  resistance  to  CHL  (P  <  0.0001)  and
OX (P  <  0.0001)  in  HIV+  patients,  compared  to
IV− patients.  Resistance  of  Serratia  sp.  to  AMO
P = 0.005),  AMC  (P  =  0.005),  and  CHL  (P  =  0.005)  was
igniﬁcantly  higher  in  HIV+  patients  than  in  HIV−
atients  (Table  S4;  supporting  information).
The blood  cells  (total  white  globules)  involved
n the  defense  of  the  organism,  particularly  the
ymphocytes,  the  monocytes  and  the  granulocytes,Please  cite  this  article  in  press  as:  Marbou  WJT,  Kuete  V.  B
infected  and  non-infected  patients  at  Mbouda  AD  LUCEM  
http://dx.doi.org/10.1016/j.jiph.2016.04.009
ere counted.  Table  S5  compares  the  principal
nomalies of  the  white  globules  observed  among
IV+  and  HIV−  patients.  It  could  be  observed  that
r
n
Figure  3  Distribution  of  CRP  in  HIV− and  Htios  in  HIV− and  HIV+  patients:  37  (HIV−) and  68  (HIV+).
he  HIV+  individuals  had  more  pronounced  lym-
hopenia  than  the  HIV−  population.
The CD4  and  CD8  lymphocytes  and  their  ratios
ere determined.  Their  blood  levels  were  deter-
ined according  to  the  published  values  [8—10]
epresented  in  Fig.  2. It  appeared  that  a bacte-
ial infection  does  not  involve  a reduction  in  the
lood rates  of  CD4  lymphocytes  (normal  value:
00—1500 cells/L)  and  CD8  lymphocytes  (normal
alue: less  than  1000  cells)  in  the  HIV−  popula-
ion. In  66.2%  of  HIV+  patients,  the  CD4  lymphocyte
ate was  less  than  500  cells/L  of  blood  (with  11.8%
ess than  100  cells,  13.2%  ranging  between  100  and
00 cells  and  41.2%  ranging  between  201  and  500).  A
roportion of  92.6%  of  HIV+  patients  had  a  CD4/CD8
atio less  than  1  (normal  value:  1—2),  compared
o the  HIV−  patients,  who  had  blood  CD4  lympho-
yte levels  of  500  cells/L,  which  was  higher  than
hat of  CD8  lymphocytes,  which  ranged  between
00 and  1000  cells/L,  and  their  ratio  (CD4/CD8
atio) ranged  between  1  and  2,  corresponding  to
he normal  values.acterial  resistance  and  immunological  proﬁles  in  HIV-
Hospital  in  Cameroon.  J  Infect  Public  Health  (2016),
C-reactive  protein  was  also  quantiﬁed,  and  the
esults are  depicted  in  Fig.  3. It  appeared  that  a
ormal C-reactive  protein  blood  level  (less  than
IV+  patients:  37  (HIV−) and  68  (HIV+).
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6  
6  mg/L)  was  observed  in  the  majority  of  the
seropositive (83.8%)  and  in  54.1%  of  the  HIV−
patients  (all  presenting  a  bacterial  infection).  How-
ever, a  blood  rate  higher  than  6  mg/L  was  observed
in 45.9%  of  the  HIV−  patients,  compared  to  16.2%
of the  HIV+  patients.  In  addition,  a  very  high  CRP
blood rate  (greater  than  40  mg/L)  was  observed  in
18.9% of  the  HIV−  patients,  compared  to  only  2.9%
of HIV+  individuals.
Table  S6  summarizes  laboratory  parameters  with
bacterial  resistance  to  less  or  more  than  three  fam-
ilies of  antibiotics  according  to  HIV  status.  It  could
be deduced  that  lymphocytes  and  granulocytes  had
higher average  values,  and  the  CD4/CD8  ratio  was
higher,  while  CRP  had  lower  average  values  in  HIV+
patients  than  in  HIV−  patients,  when  the  enteric
bacteria were  not  multi-drug  resistant  (resistance
to more  than  three  families  of  antibiotics).
Discussion
Bacterial  resistance  to  antibiotics  is  the  aptitude
of bacteria  to  grow  in  the  presence  of  an  antibi-
otic concentration  higher  than  that  inhibiting  the
majority of  the  same  species  [11].  Multi-resistance
is deﬁned  as  the  resistance  of  a  bacterium  to  more
than three  families  of  antibiotics  [12].  In  this  work,
we studied  the  organization  of  the  defense  system
of HIV+  and  HIV−  patients  in  connection  with  the
resistance  of  the  bacteria  responsible  for  enteric
infections in  the  Mbouda  AD  LUCEM  hospital.
The high  incidence  of  HIV-infected  adults  (31—50
years old)  found  in  our  study  of  55.88%  was  com-
parable to  that  found  by  Ouedraogo  et  al.  [13]  in
Ouagadougou  and  Saliou  et  al.  [14]  in  the  G-spot
hospital. This  period  corresponds  to  that  of  high
sexual  activity  and  therefore  greater  exposure  to
the risk  of  sexually  transmitted  infections.
The  present  results  revealed  that  the  distri-
butions of  infections  with  E.  coli  were  highest
in both  HIV+  and  HIV−  patients,  which  could  be
explained by  E.  coli  being  the  principal  bacterium
that normally  colonizes  the  intestine  [15].  The
high prevalence  of  Klebsiella  sp.  infections  in  HIV+
patients  (29.4%)  compared  to  HIV−  (2.7%)  patients
could be  due  to  the  disordered  state  of  the  defense
mechanisms of  HIV-infected  persons.  These  results
were in  conformity  with  those  obtained  by  Pupulin
and collaborators  in  2009,  who  reported  that  49%
of the  diarrhea  in  HIV−  patients  were  caused  by
Escherichia coli  and  13%  by  Klebsiella  sp.  [16].Please  cite  this  article  in  press  as:  Marbou  WJT,  Kuete  V.  B
infected  and  non-infected  patients  at  Mbouda  AD  LUCEM  
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This study  thus  revealed  that  bacterial  agents
were signiﬁcantly  associated  with  increased  resis-
tance to  antibiotics,  such  as  CRO,  GEN,  CHL,
and DOX  for  Klebsiella  sp.,  GEN  and  CIP  for
s
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nterobacter  sp.,  GEN  for  Citrobacter  sp.,  CHL
nd DOX  for  Salmonella  sp.  and  AMO,  AMC,  and
HL for  Serratia  sp.,  in  HIV+  patients,  compared
o HIV−  patients.  These  ﬁndings  were  in  accor-
ance with  previous  studies  [17,18].  The  resistance
f Klebsiella  sp.  could  be  due  to  over-expression  of
he efﬂux  pumps  of  the  Resistance  Nodulation  Cell
ivision (RND)  type  [19—21].  The  Enterobacter  sp.
esistance to  GEN  (25%)  and  CIP  (37.5%)  found  in
ur study  among  HIV-seropositive  patients  was  close
o previously  reported  data  [22]. The  resistance  of
almonella  sp.  to  CHL  (75%)  and  DOX  (75%)  could
e due  to  the  use  of  antibiotics  that  induced  the
roduction by  the  bacteria  of  enzymes  destroying
he antimicrobials  [23]. We  also  observed  a  resis-
ance Serratia  sp.  to  CIP  (50%),  CRO  (50%)  and  CHL
50%) in  the  HIV−  group.  This  resistance  of  Serra-
ia sp.  to  CRO  could  be  the  result  of  an  induction
y these  bacteria  of  the  synthesis  of  cephalospori-
ases [24]. The  increase  in  bacterial  resistance  to
ntibiotics  tested  among  HIV+  patients  compared
o HIV−  patients  could  be  related  to  the  frequent
xposure of  HIV+  patients  to  antibiotics  within  the
ramework  of  their  follow  ups.
The HIV+  patients  had  more  pronounced  lym-
hopenia than  the  HIV−  patients  as  observed  in
his study.  The  lymphopenia  found  in  36.8%  of  HIV+
atients was  twice  as  high  as  the  value  published
y Oumar  et  al.  [25]  in  Mali  and  Loua  et  al.  [26]
n  Guinea  Conakry.  These  anomalies  were  probably
aused by  infection  with  HIV  and  the  drugs  used
ithin the  framework  of  the  follow-up  of  these
atients.
On the  level  of  CD4  and  CD8  lymphocytes,  we
bserved a reduction  in  the  blood  rates  (blood
ate of  CD4  lymphocytes  less  than  500  cellules/L:
6.2%) among  HIV+  patients.  These  results  were
igher than  those  obtained  by  Dokekias  et  al.  [26]
n  Congo  Brazzaville,  Loua  et  al.  [27]  in  Guinea
onakry and  Mouhari-Touré  et  al.  [28]  in  Togo.  In
he present  study,  we  observed  that  the  CD4/CD8
atio was  generally  less  than  1  among  the  HIV-
eropositive patients.  These  values  are  very  closed
o the  results  of  Loua  et  al.  [26]  in  2011  (92.6%
ersus 88%)  in  the  hematological  proﬁles  of patients
nfected  with  HIV  in  Guinea  Conakry.  These  reduc-
ions in  CD4  lymphocytes  and  CD4/CD8  ratio  could
e related  to  infection  with  HIV.  Indeed,  this  virus
nfects  the  CD4  lymphocytes,  which  is  the  head  of
he orchestra  of  the  immune  reactions,  causing  a
isordered state  of  the  host’s  defense  system.
Concerning  CRP,  the  results  presented  hereacterial  resistance  and  immunological  proﬁles  in  HIV-
Hospital  in  Cameroon.  J  Infect  Public  Health  (2016),
howed that  45.9%  of  the  HIV−  patients  had  blood
ates higher  than  6  mg/L,  compared  to  16%  of
IV+ individuals.  This  weak  blood  rate  among  HIV+
atients  could  be  attributed  to  the  destruction  of
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acterial  resistance  and  immunological  proﬁles  in  H
he  CD4  lymphocytes  and  other  cells,  which  are
roducers  of  pro-inﬂammatory  cytokines,  such  as
nterleukin  6,  which  induces  CRP  synthesis  at  the
evel of  the  hepatocytes  [29—31].
Enteric  bacteria  were  more  multi-drug  resis-
ant in  the  HIV+  (79.4%)  patients  than  in  the  HIV−
atients  (29.7%).  This  increase  in  multi-resistance
mong HIV+  patients  could  be  due  either  to  pro-
hylactic antibiotherapy  used  for  the  prevention  of
pportunistic  infections  when  the  CD4/CD8  ratio
ecreases  during  HIV  infection  or the  potential
ntimicrobial  activity  of  some  antiretroviral  drugs.
Low average  values  of  CD4/CD8  ratio  and  CRP
nd high  average  values  of  lymphocytes  and  granu-
ocytes  in  HIV+  patients  compared  to  HIV−  patients
ere observed  in  this  study  when  the  enteric  bacte-
ia were  drug  resistant.  Acute  infection  with  HIV
auses  a  production  of  cells  of  the  immune  system,
uch as  lymphocytes  and  granulocytes,  and  with
ime, these  cells  are  destroyed,  probably  explaining
he appearance  of  bacterial  drug-resistance.
The data  of  this  study  might  not  be  represen-
ative of  the  entire  HIV-positive  and  HIV-negative
opulations of  Mbouda;  however,  they  could  be  of
nterest to  physicians  and  other  health  profession-
ls in  Cameroon,  given  that  they  were  collected  in
 reference  health  center  involved  in  the  manage-
ent of  HIV/AIDS  and  associated  diseases.  Because
nly one  health  center  and  a  limited  number  of
atients were  involved  in  the  present  work,  further
tudies will  be  performed  to  increase  the  reliability
f these  ﬁndings.
onclusions
he  present  study  revealed  that  the  prevalence  of
nteric bacteria,  as  well  as  resistant  phenotypes,
as higher  in  HIV-infected  persons.  The  anomalies
bserved in  HIV+  patients  were  probably  caused
y immunodeﬁciency  due  to  HIV  infection.  Hence,
he resistance  proﬁles  of  bacteria  should  be  con-
idered  in  HIV-infected  patients  to  improve  their
ealth  care.  However,  this  work  also  indicated  the
eed for  adequate  biological  follow-up  for  the  best
onitoring  of  persons  in  Cameroon  infected  with
IV.
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